Pages that link to "Q35665842"

The following pages link to HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug (Q35665842):

Displaying 21 items.

• The β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion Mechanisms (Q26747003) (← links)
• Maraviroc: a review of its use in HIV infection and beyond (Q26778504) (← links)
• Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor. (Q30378764) (← links)
• Controlling the HIV/AIDS epidemic: current status and global challenges (Q30420558) (← links)
• A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity. (Q30654651) (← links)
• Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics (Q34310045) (← links)
• Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study (Q35071940) (← links)
• Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists (Q35867443) (← links)
• Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures (Q36086642) (← links)
• A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations (Q36827946) (← links)
• Astrocytes Resist HIV-1 Fusion but Engulf Infected Macrophage Material (Q37651758) (← links)
• Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution (Q37703084) (← links)
• Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors (Q38076139) (← links)
• HIV-1 diversity in the envelope glycoproteins: implications for viral entry inhibition (Q38079744) (← links)
• Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition (Q38196457) (← links)
• Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies (Q38822845) (← links)
• Effects of sequence changes in the HIV-1 gp41 fusion peptide on CCR5 inhibitor resistance (Q39361526) (← links)
• V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc (Q41808324) (← links)
• Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion. (Q52689038) (← links)
• Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings (Q57025930) (← links)
• Synchronization Temperature Determines the Location of RSV Fusion During Entry in Cultured Cells (Q116166892) (← links)